Neurology: Merging innovative care and cutting edge research

The doctors and scientists within our esteemed network of medical facilities’ Department of Neurology are world leaders in cutting-edge research, new treatments and medical procedures.

Treating Neurodegenerative Diseases:

• The hospitals we collaborate with have garnered worldwide recognition for a breakthrough protocol for the treatment of ALS.
• The achievements in stem cell research and neurodegenerative diseases–multiple sclerosis (MS), ALS, epilepsy, and Parkinson’s disease among them–are groundbreaking.
• Of special interest are the surgical therapy of essential tremor and Parkinson’s disease by way of deep brain stimulation or radiofrequency ablation.

Deep brain stimulation (DBS) is a surgical treatment used for specific aspects of Parkinson’s disease, primarily targeting movement symptoms and certain medication side effects. It may also alleviate some non-motor symptoms like sleep disturbances and pain. However, DBS does not cure or halt disease progression.

Considered a significant advancement since the introduction of levodopa, DBS is most effective for those with disabling tremors, wearing-off spells, and medication-induced dyskinesias, with benefits lasting at least five years. However, it may not be suitable for all Parkinson’s disease, particularly those with speech, swallowing, cognitive, or gait issues.

• Our affiliated hospitals are renowned for their cutting-edge protocols in the treatment of multiple sclerosis (MS) and bone marrow transplantation (BMT) for MS patients.

20 years of research across international centers, has enabled EBMT (European Bone marrow transplant) to review their clinical evidence, registry and activity and mechanism of actions of hematopoietic stem cell transplantation in multiple sclerosis. Currently it is the fastest growing indication for this treatment. In Europe, there is increasing support for its use in highly active relapsing remitting MS failing to respond to at least one disease modifying treatment and it may have a potential role in progressive MS with significant inflammatory component. It’s even considered for treatment naïve patient in very special indication of malignant MS with high disability at the first relapse.

Treating strokes and other brain injuries:

• The hospital’s Endovascular Neurosurgery and Interventional Neuro-Radiology (INR) Unit treats strokes and injuries such as brain hemorrhages, tumors, arterial-venous malformations, and traumatic injuries. These disorders may affect patients of all ages ranging from premature babies and young children to adults and geriatric patients.
• Our partner hospitals provide specialized stroke rehabilitation programs featuring various therapies tailored to help individuals relearn skills lost after a stroke. Depending on the affected parts of the brain, rehabilitation targets movement, speech, strength, and daily living skills. These programs aim to restore independence and enhance quality of life. Innovative approaches such as state-of-the-art hyperbaric chambers or personalized rehabilitation scenarios in dedicated centers may be incorporated to optimize recovery.

Other widespread neurological conditions are treated also in the center, including: headaches, backaches, muscle aches, weakness and dizziness, loss of consciousness and many other syndromes.

Contact our representative to learn more.